Biotech has returned 20 percent for investors this year. Biogen IDEC CEO George Scangos, discusses the recent FDA approval of his company's drug, which is its first pill for multiple sclerosis.
Video (5:35)
Biogen IDEC CEO on Multiple Sclerosis Pill
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.